# mRNA vaccines: Materials

Source page: https://www.materialinsights.org/technologies/mrna_vaccines/tech-materials/

#### Materials it needs

The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
 Uses

- [Enz Industrial enzymes](https://www.materialinsights.org/chemicals/enzymes/) criticality low Enzymes copy the mRNA from a DNA template in a cell-free process ^[2].
- [Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/) criticality medium Lipids form the nanoparticles that protect the mRNA and carry it into cells ^[3].
- [Rgt Reagents and high-purity lab chemicals](https://www.materialinsights.org/chemicals/lab_reagents/) criticality low The modified RNA building blocks are high-purity specialist chemicals ^[1].
 Needs

- [Qz Silica sand](https://www.materialinsights.org/commodities/industrial_sand/) criticality low Doses are filled into glass vials, and glass is made mainly from silica sand.

as of 2026-11-11. No source gives material amounts per dose; criticality is the writer's judgement. Lipids rank medium because the particles need specialised lipids, a judgement no opened source quantifies.

#### Critical materials

The materials whose supply could hold it back

- No bulk raw material limits mRNA vaccines; the inputs are small amounts of specialised chemicals and lipids.
- Patents are a smaller barrier than they were: the early mRNA patent claims of 1989 and 1990 had a 17-year term and are now in the public domain ^[3].
- Cold storage can be a practical constraint on reaching remote places, since the doses must be kept cold from factory to clinic.

as of 2026-11-11

#### Sources

1. [Press release: The Nobel Prize in Physiology or Medicine 2023](https://www.nobelprize.org/prizes/medicine/2023/press-release/) The Nobel Assembly at Karolinska Institutet, 2023
2. [mRNA vaccines - a new era in vaccinology](https://www.nature.com/articles/nrd.2017.243) Nature Reviews Drug Discovery (N. Pardi, M. J. Hogan, F. W. Porter and D. Weissman), 2018
3. [The tangled history of mRNA vaccines](https://media.nature.com/original/magazine-assets/d41586-021-02483-w/d41586-021-02483-w.pdf) Nature 597, 318 to 324 (Elie Dolgin), 2021

## Other sections

- [Summary](https://www.materialinsights.org/technologies/mrna_vaccines/index.md)
- [Overview](https://www.materialinsights.org/technologies/mrna_vaccines/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/mrna_vaccines/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/mrna_vaccines/tech-evolution/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/mrna_vaccines/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/mrna_vaccines/tech-industries/index.md)
